NEUROLIEF
Neurolief has developed a breakthrough non-invasive Brain Neuromodulation Technology.
NEUROLIEF
Industry:
Electronics Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Yoqne`am `illit, HaZafon, Israel
Country:
Israel
Website Url:
http://www.neurolief.com
Total Employee:
11+
Status:
Active
Total Funding:
1000 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Person Schema Cloudflare Hosting Gravatar Profiles Cloudflare DNS
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Healthwire
Healthwire is a health-tech startup.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Champel Capital
Champel Capital investment in Series A - NeuroLief
Terra Venture Partners
Terra Venture Partners investment in Seed Round - NeuroLief
Official Site Inspections
http://www.neurolief.com
- Host name: 172.67.69.251
- IP address: 172.67.69.251
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeuroLief"
Neurolief - Shaping the Future of Mental HealthCare
Neurolief’s pioneering approach marks a major leap forward in the treatment of depression. By combining cutting-edge technology with personalized home-based care, we’re transforming …See details»
About us - neurolief.com
At Neurolief, we’re committed to bringing relief to people suffering from mental health and neurological disorders. As pioneers in mental healthcare, we’ve developed the world’s first and …See details»
Neurolief - Crunchbase Company Profile & Funding
Neurolief is a neuromodulation company dedicated to bringing relief to patients suffering from mental health and neurological disorders. The company consists of highly experienced professionals with a proven track record in neuroscience, …See details»
Neurolief Announces Positive Results from the MOOD …
TAMPA, Fla., July 18, 2023 /PRNewswire/ -- Neurolief, a medical neurotechnology innovator focused on neurological and neuropsychiatric disorders, today announced positive results from a planned...See details»
Relivion® Wearable Brain Neuromodulation …
Mar 2, 2021 · Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system.See details»
Neurolief - Org Chart, Teams, Culture & Jobs - The Org
View Neurolief's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Neurolief Announces Breakthrough Results from …
Jun 25, 2024 · Neurolief's non-invasive medical technology, designed for clinic and at-home treatment, marks a significant advancement in the management of TRD, offering new hope for millions of patients...See details»
Neurolief Awarded Breakthrough Device Designation from FDA for …
Aug 10, 2020 · A wearable device, the Relivion®DP system is designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who …See details»
FDA approves Neurolief’s Relivion neuro system to treat migraine
Mar 3, 2021 · Relivion is claimed to be the first non-invasive multi-channel brain neuromodulation system for at home treatment of neurological disease called acute migraine, which is affecting …See details»
Neurolief Appoints Neuromodulation Industry Leader …
Dec 13, 2022 · Neurolief, a medical neurotechnology innovator, announces the appointment of Scott Drees as Chief Executive Officer and Director. "I am thrilled to welcome Scott," said Raphael Ben Dror, Neurolief Chairman of the Board.See details»
Neurolief Presents Groundbreaking Study Results of its Proliv™Rx …
TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ -- Neurolief, a leading pioneer in neuromodulation technology, recently unveiled its pivotal multicenter RCT clinical study results for its Prolivâ„¢Rx …See details»
Neurolief Company Profile - Office Locations, Competitors, …
Neurolief is a company that develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. It offers …See details»
Neurolief's neuromodulation digital treatment for migraine gets …
Jul 10, 2019 · Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital …See details»
Neurolief’s neuromodulation device approved as migraine therapy …
Jan 10, 2024 · US-based Neurolief’s neuromodulation device, Relivion has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) for at-home use in the acute …See details»
Relivion Noninvasive Neuromodulation System Cleared for Acute …
Mar 2, 2021 · Neurolief, a neurotechnology company, today announced that the FDA has cleared its noninvasive multichannel brain neuromodulation system, Relivion, for the at-home …See details»
Neurolief Appoints Neuromodulation Industry Leader Scott Drees …
TAMPA, Fla., Dec. 13, 2022 /PRNewswire/ -- Neurolief, a medical neurotechnology innovator, announces the appointment of Scott Drees as Chief Executive Officer and Director. "I am …See details»
Neurolief Announces First Patient Enrolled in Clinical Study …
Sep 23, 2021 · Dedicated to bringing relief to patients suffering from chronic neurological and neuropsychiatric disorders, Neurolief is creating a digital therapeutics platform of wearable …See details»
Neurolief gets FDA breakthrough device for Relivion DP to treat …
Aug 11, 2020 · Neurolief has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its Relivion DP system to treat major depression.See details»
Neurolief Announces Exclusive Licensing Agreement with …
Jul 7, 2021 · Relivion is a non-invasive brain neuromodulation device that is placed around the head and delivers stimulation to the occipital and trigeminal nerves. This creates a cumulative …See details»
Neurolief Announces Positive Results From RIME - Business Wire
Jan 6, 2021 · TAMPA, Fla. & NETANYA, Israel-- ( BUSINESS WIRE )-- Neurolief, a neurotechnology innovator, today announces findings of the RIME US pivotal trial that …See details»